home / stock / clzny / clzny quote
Last: | $14.66 |
---|---|
Change Percent: | 0.0% |
Open: | $14.66 |
Close: | $14.66 |
High: | $14.66 |
Low: | $14.66 |
Volume: | 147 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$14.66 | $14.66 | $14.66 | $14.66 | $14.66 | 147 | 04-25-2024 |
$14.91 | $14.91 | $14.91 | $14.91 | $14.91 | 123 | 04-24-2024 |
$14.34 | $0 | $14.34 | $0 | $0 | 62 | 04-23-2024 |
$14.34 | $0 | $14.34 | $0 | $0 | 138 | 04-22-2024 |
$14.34 | $0 | $14.34 | $0 | $0 | 99 | 04-19-2024 |
$14.34 | $14.75 | $14.34 | $14.75 | $14.34 | 332 | 04-18-2024 |
$14.76 | $14.76 | $14.76 | $14.76 | $14.76 | 308 | 04-17-2024 |
$14.98 | $14.98 | $14.98 | $14.98 | $14.98 | 258 | 04-16-2024 |
$14.5 | $14.5 | $14.5 | $14.5 | $14.5 | 1,103 | 04-15-2024 |
$14.55 | $14.34 | $14.55 | $14.55 | $14.34 | 212 | 04-12-2024 |
$14.05 | $0 | $14.05 | $0 | $0 | 174 | 04-11-2024 |
$14.05 | $14.05 | $14.05 | $14.05 | $14.05 | 684 | 04-10-2024 |
$14.53 | $14.53 | $14.53 | $14.53 | $14.53 | 123 | 04-09-2024 |
$14.94 | $14.94 | $14.94 | $14.94 | $14.94 | 214 | 04-08-2024 |
$14.32 | $14.32 | $14.32 | $14.32 | $14.32 | 2,614 | 04-05-2024 |
$14.32 | $14.32 | $14.32 | $14.32 | $14.32 | 1,174 | 04-04-2024 |
$14.37 | $14.5 | $14.37 | $14.5 | $14.37 | 578 | 04-03-2024 |
$13.69 | $13.69 | $13.69 | $13.69 | $13.69 | 196 | 04-02-2024 |
$13.52 | $0 | $13.52 | $0 | $0 | 143 | 04-01-2024 |
$13.52 | $13.52 | $13.52 | $13.52 | $13.52 | 791 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Clariant AG ADR Company Name:
CLZNY Stock Symbol:
OTCMKTS Market:
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
Clariant AG ADR (CLZNY) is expected to report for Q4 2023
NEW YORK, June 19, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA), Enochian Biosciences, Inc. (NASDAQ: ENOB), Corcept Therapeutics, Inc. (NASDAQ: CORT), and Cla...